Reach Us +44-1477412632
Use Of HbA1C Testing To Diagnose Pre-diabetes In High Risk Overweight And Obese Children: A Comparison With Fasting Glucose And HOMA-IR | 6249
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Use of HbA1C testing to diagnose pre-diabetes in high risk overweight and obese children: A comparison with fasting glucose and HOMA-IR

3rd World Congress on Diabetes & Metabolism

Sushma Sharma

AcceptedAbstracts: J Diabetes Metab

DOI: 10.4172/2155-6156.S1.020

Objective: This study aimed to compare the discriminating power of HbA1C with other Pre-diabetes diagnostic tests specifically in high-risk overweight and obese African American children. Research Design and Methods: A cross-sectional analysis was performed on a sample of 172 children (70 boys, 102 girls) aged 9-11 years with BMI?s above the 85th percentile. Fasting glucose, insulin and HbA1C were analyzed from the plasma samples. Results: Of the 172 participants included in this analysis, 21 (12.2%) had HbA1C concentrations above the cut-off of 5.7 used to identify pre-diabetes. None (0%) of these 21 participants, however, were observed to have a glucose concentration above the pre-diabetes cut-off of 110 mg/dl, and only 13 of 21 participants had HOMA-IR above the pre-diabetes cut-off of 2.5. When compared to the previously identified glucose cut-off of 110 mg/dl and HOMA-IR cut-off of 2.5 for pre-diabetes, HbA1C showed high specificity (88 and 93%, respectively) but very low sensitivity (0 and 21%, respectively). Glucose, insulin and HOMA-IR were significantly interrelated, but HbA1C was not significantly correlated with these biochemical pre-diabetes assessment variables, nor with anthropometric (BMIz and WC) risk factors. Conclusion: Our results suggest that HbA1C had poor discrimination power to identify pre-diabetes in overweight and obese 9-11 year old African American children. Future studies are recommended to compare the feasibility, sensitivity and predictive power of different screening tests currently recommended to avoid inadequacy when screening for pre-diabetes and diabetes.